-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
01, Baiyunshan 702.7 million Yuan Baiyunshan received a total of 702.7 million yuan in government subsidies in January-December 2020, more than 1 million yuan including major new drug creation, patent award outstanding award, standardized cultivation and extraction research of Tibetan Jing mustard, Kunxian capsule top design research, high-quality development fund support, Huangpu District 2020 biopharmaceutical industry Policy incentives, industrial development support funds, consistent evaluation of equipment and upgrading projects, 2020 Provincial Department of Industry and Information Technology under the management of special funds, Guangzhou Baiyunshan Jingshotang Pharmaceutical Co., Ltd. declared the 2017 technology innovation benchmark enterprises, 2019 award, Wang Laoji Guizhou Hedgehog key investment award supplement project, 2017 deferred shutdown loss compensation and other subsidies.
02, health yuan 192.9 million health yuan in January-November 2020 received a total of 192.9 million yuan in government subsidies, more than 1 million yuan including new inhalation drug preparations and their large-scale development of major common key technology research, In 2019, the Provincial Bureau of Industry and Information Technology technology transformation project funds, the provincial science and technology innovation strategy special funds, the 13th Five-Year Key Leading Enterprises Special Fund (2019), Zhuhai Jinwan District Finance Bureau allocated Lizhu incentive support funds, Zhuhai Jinwan District Finance Bureau allocated Lizhu incentive support funds and other subsidies.
03, Lizhu Group 158.8 million Yuan Lizhu Group received a total of 158.8 million yuan in government subsidies in January-November 2020, more than 1 million yuan including the 2019 Provincial Bureau of Industry and Information Technology transformation Project funds, special funds for provincial science and technology innovation strategy, special funds for industrial enterprise structural adjustment, special funds for key leading enterprises in the 13th Five-Year Plan (2019), Xiangzhou District 2018 high-level top 100 research and development fees plus deduction of subsidy funds, Zhuhai Jinwan District Finance Bureau allocated to Li Pearl Incentive Support Fund, Zhuhai Jinwan District Finance Bureau allocated Lizhu Incentive Support Fund, received RHCG project technology subsidy (city level), 2020 provincial intelligent manufacturing pilot demonstration project, 2020 Fuqing Technology Reform Project Grant, 2019 The annual Zhuhai Free Tax Zone supports key enterprises to support funds, new coronavirus detection reagent industrialization project grants, 2020 Qingyuan City industrial enterprises after the technical transformation award supplement (Akapo sugar recovery system technology), Zhuhai Jinwan District Finance Bureau allocated Lizhu incentive support funds , innovation and entrepreneurship team district-level supporting funds and other subsidies.
04, Step Pharmaceuticals 143 million yuan Step Pharmaceuticals received a total of 143 million yuan in government subsidies in January-June 2020, more than 1 million yuan including enterprise development incentive funds, enterprise support funds and other subsidies.
05, TaiJi Group 117.3 million Taiji Group in January-October 2020 received a total of 117.3 million yuan in government subsidies, more than 1 million yuan including innovative Chinese medicine Dan seven veins The application of clinical research and development of tablets, the first batch of special funds for industry and information technology in 2020, the upgrading and promotion of standardized production techniques for two commonly used wild mutant medicinal herbs, special funds for financial support, and subsidies for industrial development in 2019.
06, Hyundai Pharmaceuticals 116.5 million Yuan Hyundai Pharmaceuticals received a total of 116.5 million yuan in government subsidies in January-September 2020, more than 1 million yuan including the second batch of scientific and technological innovation projects in 2019 Municipal Science and Technology Innovation Commission technical research project funding, the Municipal Bureau of Industry and Information Technology in 2020 multiplied the special promotion project, the Municipal Science and Technology Creation Commission 2019 enterprise research and development funding plan, flue gas ultra-low emissions project, carat refining workshop vocs governance project and other subsidies.
07, one mam than one mam than 113.9 million yuan, one mam than 2020 January-December 2020 received a total of 113.9 million yuan in government subsidies, more than 1 million yuan including the 2019 Gazelle special support funds, Guangzhou city emerging industry development subsidy funds projects, subsidies due to local support policies and other subsidies.
08, North China Pharmaceuticals 99.17 million Yuan North China Pharmaceuticals in January-July 2020 received a total of 99.17 million yuan in government subsidies, more than 1 million yuan including air pollution control projects, hebei Province, the revitalization and development of old industrial areas, environmentally friendly micro-ecological agent Spores series of product development and promotion subsidies.
09, Yifan Pharmaceuticals 95.83 million yuan Yifan Pharmaceuticals received a total of 95.83 million yuan in government subsidies in January-November 2020, more than 1 million yuan including talent introduction, staff training and other special incentives, industrial support funds, enterprise development support funds and other subsidies.
10. Prop Pharma 84.45 million Propharma received a total of 84.45 million yuan in government subsidies in January-December 2020, and more than 1 million yuan included subsidies for the development of major new drug-created children's drugs and key technologies, local financial contributions for special funds for industrial development in 2019, local financial contribution awards for key treatment drugs, medical protection materials, and capacity-building projects for the production of medical treatment equipment.
11th-20th place in order are Yisheng Pharmaceuticals, Ha Sanlian, Haizheng Pharmaceuticals, Ha Pharmaceuticals Group, Puli Pharmaceuticals, Kun Pharmaceuticals Group, Kailaiying, People's Fu Pharmaceuticals, Qi zheng Tibetan Medicine, Kang Enbei.
list of enterprises and the amount of subsidies awarded to the 21-53rd-largest company are detailed in the table below.